Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Myelodysplastic syndromes/acute myeloid leukemia : new therapeutic targets; Mechanisms of disease and novel therapy for sickle cell vasculopathy; Hodgkin lymphoma : clinical challenges and new approaches; B-cell lymphomas : new molecular targets; Chronic lymphocytic leukemia : novel therapies; Anem…
c.1 BC Cancer Agency VAN Library AV Room | Available |
Table of Contents:; Introduction; Here to help; Your child - the initial diagnosis; Your child - coping with change; Parents - coming to terms with your feelings; Siblings - helping them cope too; Communicating with your extended family and friends; The new normal; More information
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available |
"What's the difference between targeted therapy and immunotherapy? If you're a melanoma patient, you should know. Unfortunately, most melanoma literature focuses on prevention. Patients receive a terrifying, life-threatening diagnosis and subsequently find a scarcity of information on treatment opt…
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library | Available |
This book follows Annie Parker and her cancer journey, loss of family members and being one of the first women in Canada to be tested for the BRCA1 gene mutation, confirming her beliefs that her cancer were hereditary.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available |
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…